$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2016
[Published by Global Data]

Published by Global Data: 30 Jun 2016 | 27111 | In Stock
Related Topics: Clinical Trials

Introduction

Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Guillain-Barre Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Guillain-Barre Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2016 [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 3

    Report Guidance 4

    Clinical Trials by Region 5

    Clinical Trials and Average Enrollment by Country 6

    Top Countries Contributing to Clinical Trials in Asia-Pacific 8

    Top Countries Contributing to Clinical Trials in Europe 9

    Top Countries Contributing to Clinical Trials in North America 10

    Top Countries Contributing to Clinical Trials in Middle East and Africa 11

    Clinical Trials by G7 Countries: Proportion of Guillain-Barre Syndrome to Central Nervous System Clinical Trials 12

    Clinical Trials by Phase in G7 Countries 13

    Clinical Trials in G7 Countries by Trial Status 14

    Clinical Trials by Phase 15

    In Progress Trials by Phase 16

    Clinical Trials by Trial Status 17

    Clinical Trials by End Point Status 18

    Subjects Recruited Over a Period of Time 19

    Clinical Trials by Sponsor Type 20

    Prominent Sponsors 21

    Top Companies Participating in Guillain-Barre Syndrome Therapeutics Clinical Trials 22

    Prominent Drugs 23

    Clinical Trial Profile Snapshots 24

    Appendix 33

    Abbreviations 33

    Definitions 33

    Research Methodology 34

    Secondary Research 34

    About GlobalData 35

    Contact Us 35

    Disclaimer 35

    Source 36

List Of Tables
in Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2016 [Published by Global Data]

List of Tables

Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials by Region, 2016* 5

Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6

Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7

Guillain-Barre Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8

Guillain-Barre Syndrome Therapeutics Clinical Trials, Europe, Top Countries, 2016* 9

Guillain-Barre Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2016* 10

Guillain-Barre Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11

Proportion of Guillain-Barre Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 12

Guillain-Barre Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13

Guillain-Barre Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14

Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials by Phase, 2016* 15

Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 16

Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 17

Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 18

Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 19

Guillain-Barre Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 20

Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 21

Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 22

Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 23

List Of Figures, Charts and Diagrams
in Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2016 [Published by Global Data]

List of Figures

Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2016* 5

Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6

Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7

Guillain-Barre Syndrome Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 9

Proportion of Guillain-Barre Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 12

Guillain-Barre Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13

Guillain-Barre Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14

Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2016* 15

Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 16

Guillain-Barre Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 17

Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 18

Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 19

Guillain-Barre Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 20

Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 21

Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 22

Guillain-Barre Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 23

GlobalData Methodology 34

Additional Details

Publisher

Global Data

Publisher Information

Reference

27111 | GDHC3530CTIDB

Number of Pages

36

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2017
Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2017SummaryGlobalData's clinical trial re...
30 Aug 2017 by Global Data USD $2,500 More Info
Guillain-Barre Syndrome - Pipeline Insight, 2017
DelveInsight’s, “Guillain-Barre Syndrome-Pipeline Insights, 2017”, report provides comprehensive ins...
31 Jul 2017 by Delve Insight USD $1,250 More Info
Guillain-Barre Syndrome - Pipeline Insight, 2017
DelveInsight’s, “Guillain-Barre Syndrome-Pipeline Insights, 2017”, report provides comprehensive ins...
31 Jul 2017 by Delve Insight USD $1,250 More Info
Guillain - Epidemiology Forecast To 2023
DelveInsight “Guillain - Epidemiology Forecast To 2023” provides an overview of the epidemiology tre...
31 May 2017 by Delve Insight USD $2,750 More Info
Guillain-Barre Syndrome (GBS)-Market Insights, Epidemiology and Market Forecast-2023
Note*: This report requires 5-7 business days to complete.DelveInsight’s Guillain-Barre Syndrome (GB...
30 May 2017 by Delve Insight USD $4,950 More Info
Guillain-Barre Syndrome-Pipeline Insights, 2017
DelveInsight’s, “ Guillain-Barre Syndrome-Pipeline Insights, 2017”, report provides in depth insight...
30 May 2017 by Delve Insight USD $1,250 More Info
Malaysia Intravenous Immunoglobulin (IVIG) Market by Product Types (IgG, IgA, IgM, IgE and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Immune Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barré Syndrome, Kawasaki Disease,
CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS FOR STAKEHOLDERS1.3. KEY MARKET SEGME...
24 May 2017 by Allied Market Research USD $2,850 More Info
Guillain-Barre Syndrome - Pipeline Review, H1 2017
Guillain-Barre Syndrome - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutic...
09 May 2017 by Global Markets Direct USD $2,000 More Info
Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2016
Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial re...
21 Sep 2016 by Global Data USD $2,500 More Info
IVIG Market: By Application (Hypogammaglobulinemia, CIDP, Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome), By Route of Administration (Intravenous, Subcutaneous), By Geography-Forecast (2016-2021)
Immunoglobulin refers to the breakdown of blood plasma that contains antibody and Intravenous immuno...
26 Feb 2016 by Industry ARC USD $5,250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2016 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)